Neurofibromas in children with neurofibromatosis 1

Journal of Child Neurology

Volumn 17, Issue 8, 2002, Pages 585-591

  Rosser, Tena ^a   Packer, Roger J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOSTATIN; ANTINEOPLASTIC AGENT; KETOTIFEN FUMARATE; PIRFENIDONE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RETINOIC ACID; THALIDOMIDE;

ADOLESCENT; ADULTHOOD; AUTOSOMAL DOMINANT DISORDER; BENIGN TUMOR; CAFE AU LAIT SPOT; CANCER INCIDENCE; CHILD; CHILDHOOD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN GENETICS; MALE; MALIGNANT NEURILEMOMA; MALIGNANT NEURINOMA; MORBIDITY; MORTALITY; NEUROFIBROMA; NEUROFIBROMATOSIS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 0036700963     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700808     Document Type: Review

References (36)

1. National Institutes of Health Consensus Development Conference: Neurofibromatosis: conference statement. Arch Neurol 1988;45:575-578.
2. Scheithauer BW, Woodruff JM, Erlandson RA: Tumors of the Peripheral Nervous System. Washington, DC, Armed Forces Institute of Pathology, 1999.
3. Korf BR: Plexiform neurofibromas. Am J Med Genet 1999;89:31-37.
4. Friedman JM, Birch PH: Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1, 728 patients. Am J Med Genet 1997; 70:138-143.
5. North KN: Neurofibromatosis type 1: Review of the first 200 patients in an Australian clinic. J Child Neurol 1993;8:395-402.
6. Woodruff JM: Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet 1999;89:23-30.
7. Liebermarm F, Korf BR: Emerging approaches toward the treatment of neurofibromatoses. Genet Med 1999; 1: 158-164.
8. Packer RJ, Gutmann DH, Rubenstein A, et al: Plexiform neurofibromas in neurofibromatosis 1: Towards biologic-based therapy. Neurology 2001;58:1461-1470.
9. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore, Johns Hopkins University Press, 1999.
10. Cnossen MH, de Goede-Bolder A, van den Broek KM, et al: A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child 1998;78:408-412.
11. Waggoner DJ, Towbin J, Gottesman G, Gutmann DH: Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet 2000;92:132-135.
12. Huson SM, Harper PS, Compston DAS: Von Recklinghausen neurofibromatosis: A clinical and population study in south-east Wales. Brain 1988; 111: 1355-1381.
13. Riccardi VM: Type I neurofibromatosis and the pediatric patient. Curr Prob Pediatr 1992;22:66-106.
14. Tonsgard JH, Short MP, Kwak S, Dachman A: Computed tomographic imaging in neurofibromatosis, abstract. Ann Neurol 1996;40:311.
15. Schorry EK, Crawford AH, Egelhoff JC, et al: Thoracic tumors in children with neurofibromatosis-1. Am J Med Genet 1997;74:533-537.
16. Chung CJ, Armfield KB, Mukherji SK, et al: Cervical neurofibromas in children with NF-1. Pediatr Radial 1999;29:353-356.
17. Gutmann DH, Aylsworth A, Carey JC, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57.
18. Dugoff L, Sujansky E: Neurofibromatosis type 1 and pregnancy. Am J Med Genet 1996;66:7-10.
19. North KN: Neurofibromatosis 1 in childhood. Semin Pediatr Neurol 1998;5:231-242.
20. Thakkar SD, Feigen U, Mautner VF: Spinal tumours in neurofibromatosis type 1: An MRI study of frequency, multiplicity and variety. Neuroradiology 1999;41:625-629.
21. Needle MN, Cnaan A, Dattilo J, et al: Prognostic signs in the surgical management of plexiform neurofibroma: The Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr 1997; 131:678-682.
22. Riccardi VM: Mast-cell stabilization to decrease neurofibroma growth. Arch Dermatol 1987; 123:1011-1016.
23. Riccardi VM: A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 1993;129:577-581.
24. Gupta A, Cohen B, Ruggierri P, et al: A phase I study of thalidomide for the treatment of plexiform. neurofibroma in patients with neurofibromatosis 1 (NFl). Neurology 2000;54(Suppl 3):12-13.
25. Kirsch M, Strasser J, Allende R, et al: Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 1998;58:4654-4659.
26. Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: Results of a prospective, open-label phase II study. Am J Respir Crit Care Med 1999; 159:1061-1069.
27. Weiss B, Bollag G, Shannon K: Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. Am J Med Genet 1999;89:14-22.
28. Yan N, Ricca C, Fletcher J, et al: Farnesyltransferase inhibitors block the neurofibromatosis type 1 (NF1) malignant phenotype. Cancer Res 1995;55:3569-3575.
29. Maravilla, KR, Bowen BC: Imaging of the peripheral nervous system: Evaluation of peripheral neuropathy and plexopathy. AJNR Am J Neuroradioll.998; 19:1011-1023.
30. Committee on Genetics: Health supervision for children with neurofibromatosis. Pediatrics 1995;96:368-372.
31. Wanebo JE, Malik JM, VanderBerg SR, et al: Malignant peripheral nerve sheath tumors: A clinicopathologic study of 28 cases. Cancer 1993;71:1247-1253.
32. Ducatman B, Scheithauer BW, Piepgras DG, et al: Malignant peripheral nerve sheath tumors. A clinicopathological study of 120 cases. Cancer 1986;57:2006-2021.
33. Leroy K, Dumas V, Martin-Garcia N, et al: Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: A clinicopathologic and molecular study of 17 patients. Arch Dermatol 2001; 137:908-913.
34. Matsui I, Tanimura M, Kobayashi N, et al: Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72:2746-2754.
35. Raney B, Schnaufer L, Ziegler M, et al: Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984. Cancer 1987;59:1-5.
36. Shearer P, Parham D, Kovnar E, et al: Neurofibromatosis type 1 and malignancy: Review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 1994;22:78-83.